Semantic Dementia: Clinical Trials

16 trials for Semantic Dementia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 4 recruiting, 2 active not recruiting, 2 enrolling by invitation. 7 Not applicable, 2 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable7Completed 2, Recruiting 2, Active not recruiting 1, Enrolling by invitation 1, Unknown 1
Phase 12Active not recruiting 1, Completed 1
Phase 41Completed 1

Follow Semantic Dementia: new trials by email Literature Review of Semantic Dementia trials Research Report on Semantic Dementia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intervention for Communication Quality of Life in Primary Progressive Aphasia
Multicomponent Lexical Retrieval Cascade Training, Multicomponent Video Implemented Script Training in Aphasia - Primary Progressive Aphasia(PPA), Semantic Dementia
Not applicableRecruitingMaya Henry302026-04-012026-04-21
Revealing Engagement Dynamics Among Semantic Dementia Patients
Semantic Dementia
Not yet recruitingPower Life Sciences Inc.5002025-02-012024-01-23
Primary Progressive Aphasia Multicomponent Language Treatment Study
Multicomponent Lexical Retrieval Training (Multi-LRT), Multicomponent Video Implemented Script Training in Aphasia (Multi-VISTA), Multicomponent Communication Partner Training (Multi-CPT) - Primary Progressive Aphasia, Semantic Dementia
Not applicableEnrolling by invitationUniversity of Texas at Austin212023-05-022025-10-08
Home-Based Exercise in Primary Progressive Aphasia (HEPPA)
Home-based multicomponent exercise intervention program - Primary Progressive Aphasia, Neurodegenerative Diseases
Not applicableCompletedMontreal Heart Institute132023-04-052025-02-06
Memory and Social Interactions
Learning new information - Alzheimer Disease, Semantic Dementia
RecruitingUniversity Hospital, Caen1922023-03-102024-09-20
Veri-T: A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology
Verdiperstat - Semantic Dementia
Phase 1Active not recruitingPeter Ljubenkov, MD642022-04-142026-07-06
Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders
C-11 PiB, AV1451 Tau, C-11 ER176 - PSP, CBD
Enrolling by invitationMayo Clinic5002020-11-012025-11-21
Metacognition in Semantic Dementia: Comparison With Alzheimer's Disease
Metacognition tests - Semantic Dementia, Alzheimer Disease
CompletedUniversity Hospital, Grenoble402020-10-162023-08-07
Evaluation of a Transcranial Stimulation With Direct Current on Language Disorders in Semantic Dementia
Transcranial stimulation - Semantic Dementia
Not applicableUnknownAssistance Publique - Hôpitaux de Paris802018-05-162024-01-17
Treatment for Speech and Language in Primary Progressive Aphasia
Lexical Retrieval Training (LRT), Video-Implemented Script Training for Aphasia (VISTA) - Primary Progressive Aphasia, Semantic Dementia
Not applicableActive not recruitingUniversity of Texas at Austin602017-07-012025-11-13
The Swedish BioFINDER 2 Study
Flutemetamol F18 Injection, [18F]-RO6958948, Elecsys (Roche) Abeta42, Ttau and Ptau - Dementia, Alzheimer Disease
Not applicableRecruitingSkane University Hospital29502017-05-152026-04-06
Diagnosing Frontotemporal Lobar Degeneration
Observational Study - Corticobasal Syndrome, Progressive Supranuclear Palsy
RecruitingUniversity Health Network, Toronto1002015-08-012025-03-30
Evaluation and Characterization of Behavioural Disorders and Dementias by the Behavioural Dysexecutive Syndrome Inventory (BDSI)
prevalence of behavioural dysexecutive syndrome - Frontotemporal Dementia, Huntington Disease
CompletedCentre Hospitalier Universitaire, Amiens492013-01-292020-07-20
PiB PET Scanning in Speech and Language Based Dementias
C-11 PiB, F-18 FDG - PPA, Primary Progressive Aphasia
Phase 1CompletedMayo Clinic1682010-03-012015-12-22
Language Treatment for Progressive Aphasia
Errorless learning - Primary Progressive Aphasia, Nonfluent Progressive Aphasia
Not applicableCompletedBaycrest72009-08-012015-01-27
Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia
memantine, Placebo pill - Frontal Lobe Dementia, Frontotemporal Lobe Dementia
Phase 4CompletedUniversity of California, San Francisco812007-10-012020-11-17

Narrower conditions

Frontotemporal Dementia (16)  ·  Aphasia, Primary Progressive (7)  ·  Primary Progressive Nonfluent Aphasia (7)  ·  Aphasia (6)  ·  Alzheimer Disease (4)  ·  Neurodegenerative Diseases (3)  ·  Aphasia, Broca (2)  ·  Apraxias (2)  ·  Cognitive Dysfunction (2)  ·  Corticobasal Degeneration (2)  ·  Dementia (2)  ·  Memory Disorders (2)  ·  Parkinson Disease (2)  ·  Pick Disease of the Brain (2)  ·  Supranuclear Palsy, Progressive (2)

Broader conditions

Brain Diseases (16)  ·  Central Nervous System Diseases (16)  ·  Frontotemporal Lobar Degeneration (16)  ·  Metabolic Diseases (16)  ·  Nervous System Diseases (16)  ·  Neurocognitive Disorders (16)  ·  Nutritional and Metabolic Diseases (16)  ·  Proteostasis Deficiencies (16)  ·  TDP-43 Proteinopathies (16)  ·  Mental Disorders (15)  ·  Dementia (14)  ·  Neurodegenerative Diseases (13)  ·  Communication Disorders (10)  ·  Language Disorders (10)  ·  Neurobehavioral Manifestations (10)

Interventions

2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole (2)  ·  Memantine (1)  ·  Observation (1)  ·  Therapeutics (1)

Sponsors

Mayo Clinic (2)  ·  University of Texas at Austin (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Baycrest (1)  ·  Centre Hospitalier Universitaire, Amiens (1)  ·  Maya Henry (1)  ·  Montreal Heart Institute (1)  ·  Peter Ljubenkov, MD (1)  ·  Power Life Sciences Inc. (1)  ·  Skane University Hospital (1)  ·  University Health Network, Toronto (1)  ·  University Hospital, Caen (1)  ·  University Hospital, Grenoble (1)  ·  University of California, San Francisco (1)

Countries

United States (8)  ·  France (4)  ·  Canada (3)  ·  Sweden (1)  ·  Switzerland (1)

Top investigators

Maya L Henry, PhD (3)  ·  Adam L. Boxer, M.D., Ph.D. (1)  ·  Bruce Miller, M.D. (1)  ·  Erik Stomrud, MD, Phd (1)  ·  Keith A Josephs, M.D. MST, MSc (1)  ·  Louis Bherer (1)  ·  Maria C Tartaglia, M.D. (1)  ·  Michael B Gill (1)  ·  Peter Ljubenkov, MD (1)  ·  Regina Jokel, PhD (1)  ·  Stephanie M Grasso, PhD (1)

Results publications

PMID 23290598, PMID 31747967, PMID 34937781, PMID 38807183, PMID 41864233

NIH funding

R01AG073482 (1), R01DC016291 (1), R56DC016291 (1)